KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inovio Pharmaceuticals (INO) Change in Intangibles (2017)

Inovio Pharmaceuticals' Change in Intangibles history spans 5 years, with the latest figure at $1.0 million for Q4 2017.

  • For Q4 2017, Change in Intangibles changed N/A year-over-year to $1.0 million; the TTM value through Dec 2017 reached $1.0 million, changed N/A, while the annual FY2017 figure was $1.0 million, 16.67% down from the prior year.
  • Change in Intangibles for Q4 2017 was $1.0 million at Inovio Pharmaceuticals, up from -$1.0 million in the prior quarter.
  • Across five years, Change in Intangibles topped out at $1.0 million in Q2 2013 and bottomed at -$1.0 million in Q4 2015.
  • The 3-year median for Change in Intangibles is $1.0 million (2013), against an average of $600000.0.